Atlas Trials

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Clinical trial NCT01131559 · TERMINATED

Trial details

NCT number
NCT01131559
Sponsor
Lindner Center of HOPE
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
BipolarDepression
Start date
2010-01-01
Primary completion
2014-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.